Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijgo.2015.06.017 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
FIGO-GCH joint consensus statement on the current status and recommendations for the use of blind intrauterine procedures in the evaluation and management of women with suspected intrauterine pathologies.
Int J Gynaecol Obstet
December 2024
Hysteroscopy Unit, Hospital Quirón Salud, Málaga, Spain.
Historically, blind intrauterine procedures such as dilation and curettage (D&C) and blind endometrial biopsies have been the primary approach for diagnosing and managing intrauterine pathologies. However, these techniques lack direct visualization, leading to diagnostic limitations, incomplete treatment, and increased complication rates. Despite substantial advances in hysteroscopic technology, including high-definition imaging and minimally invasive instruments, blind procedures remain widely used.
View Article and Find Full Text PDFConsensus Guidelines for Delineation of Clinical Target Volumes for Intensity-Modulated Radiotherapy for Intact Cervical Cancer: An Update.
Pract Radiat Oncol
November 2024
Department of Radiation Oncology, University of Colorado, Aurora, Colorado, USA.
Purpose: Accurate target delineation is essential when using intensity-modulated radiotherapy (IMRT) for intact cervical cancer. In 2011, the Radiation Therapy Oncology Group (RTOG) published a consensus guideline using magnetic resonance imaging (MRI). The current project expands on the previous atlas by including computed tomography (CT)-based contours, contours with MRI and positron- emission- tomography (PET) registrations, the addition of common and complex scenarios, and to incorporate information on simulation and treatment planning techniques.
View Article and Find Full Text PDFSystemic hormone therapy after breast and gynecological cancers: an Italian expert group consensus opinion.
Climacteric
November 2024
Coordinator of the Italian Group of Special Interest on Menopause of the Italian Society of Obstetrics and Gynecology, Women's Wellness Foundation, Cagliari, Italy.
Article Synopsis
- * ET/HT can be cautiously used after vulvar cancers, melanoma, and certain endometrial cancers, while more caution is needed with adenocarcinomas and uterine sarcomas.
- * For breast cancer survivors, ET/HT is likely safe after ER/PR-negative cancers but should be applied carefully after ER/PR-positive cases.
Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer.
Int J Gynecol Cancer
January 2025
Early phase trial unit in oncology (CITOHL- EPSILYON), Centre pour l'lnnovation en Cancérologie de Lyon (CICLY), Lyon University Hospital (HCL), Lyon, France.
Article Synopsis
- Maintenance therapies like PARP inhibitors and bevacizumab have improved outcomes for advanced ovarian cancer patients, prompting a study to explore treatment variability across Europe.
- A Delphi study was conducted with experts to understand maintenance treatment strategies and gauge consensus on best practices.
- Key factors influencing treatment choices include tumor mutation status and perceived risk of disease progression, with high-risk cases defined by advanced FIGO stages or residual disease after initial treatment.
Multi-modality MRI radiomics phenotypes in intermediate-high risk endometrial cancer: correlations with histopathology and prognosis.
Jpn J Radiol
September 2024
Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Nanjing, 210029, China.
Objectives: This study aimed to identify the magnetic resonance imaging (MRI)-based radiomics phenotypes of intermediate-to-high-risk endometrial cancers (ECs), explore their association with histopathologic features, and compare their prognostic ability with the International Federation of Gynecology and Obstetrics (FIGO) stage.
Methods: This study retrospectively recruited 355 patients with pathologically confirmed EC from 01/2016 to 06/2023. 166(46.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!